Aspira Women's Health Inc. (AWH) Stock Analysis

Stock Overview

$0.1536

+$0.01 (+0.00%)

Volume: 0

Sector: N/A

Industry: N/A

Price Chart

Technical Indicators

Moving Averages

50-Day MA: N/A

200-Day MA: N/A

Relative Strength Index (RSI)

RSI (14): N/A

Neutral

Support & Resistance

Support: $N/A

Resistance: $N/A

52-Week Range

High: $N/A

Low: $N/A

Fundamental Data

Market Cap

N/A

P/E Ratio

N/A

EPS

$N/A

Beta

N/A

Analysis

Note: The analysis provided below is generated for informational purposes only and should not be considered as financial advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Aspira Women's Health Inc. (AWH) - Up 9.71%

Aspira's stock movement represents a strong recovery after a challenging week (-9.65%). The catalyst appears to be yesterday's fourth quarter and full-year 2024 financial results, coupled with the recent closing of a $1.37 million private placement of convertible notes announced on March 11th. As a small-cap company with a market capitalization of only about $2.7 million operating in the women's health diagnostics space, Aspira is highly responsive to operational developments and financing news. The successful capital raise likely addresses near-term liquidity concerns, while the earnings report may have showcased progress in their diagnostic technologies. The diagnostic healthcare sector continues to attract interest due to the growing emphasis on early detection and precision medicine.

Recent News

AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

prnewswire.com • March 12, 2025

Full Year 2024 Net Revenue Increased 8% Year-over-Year to $562 million Full Year 2024 Adjusted EBITDA 1 Increased 9% Year-over-Year to $116 million Second Full Year of Positive Cash from Operations and Positive Free Cash Flow 2 Company Ended Q4 2024 with $88 Million of Cash and Cash Equivalents NEW YORK , March 12, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP") and all currency is in U.S. dollars.

Read Full Article

Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes

accessnewswire.com • March 11, 2025

AUSTIN, TX / ACCESS Newswire / March 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that it has entered into a securities purchase agreement dated March 6, 2025, pursuant to which the Company has sold and issued an aggregate principal amount of $1.37 million in the form of Senior Secured Convertible Promissory Notes due March 6, 2030 (the "Convertible Notes") in a private placement (the "Private Placement") with existing and new accredited investors. The Convertible Notes will be a senior, secured obligation of the Company and interest will accrue and be payable quarterly in kind at the applicable federal rate (currently 3.34%).